Table of Contents Table of Contents
Previous Page  506 / 916 Next Page
Information
Show Menu
Previous Page 506 / 916 Next Page
Page Background

S502

25th European Congress of Psychiatry / European Psychiatry 41S (2017) S465–S520

Methods

Clinical and literature reviews.

Results

(Case report) This poster presents the case of 92-year-old

woman who lives alone with no family support who was brought

to the emergency room due to a fall. Consequently, she was diag-

nosedwith small cell lung carcinoma. Instead of the proposed short

term rehab to receive radiotherapy, the patient insisted that she be

discharged to her home. The psychosomatic team was consulted

to evaluate the patient’s capacity to make a decision regarding this

form of treatment. The psychiatrist who evaluated the patient felt

that she lacks capacity. However, palliative care felt strongly that

patient’s capacity should not be challenged, arguing that she has

been living independently, doingwell, and is agreeing to treatment.

Conclusion

We will review the most updated guidelines on how

to performa capacity evaluation, how these guidelines are incorpo-

rated in residency curriculums, andwhether residents fromvarious

specialties are being trained on evaluating decisional capacity. We

will also explore optimal ways to educate primary care physicians

on how to evaluate decisional capacity and when to seek psychia-

trists’ expertise for these evaluations.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.631

EV0302

Polydipsia and intermittent

hyponatremia

S. Ramos-Perdigues

, M.J. Gordillo , C. Caballero , S. Latorre ,

S.V. Boned , G. Miriam , P. Torres , M. De Almuedo , M.T. Sanchez ,

E. Contreras , E. Gomez , E. Sanchez , M. Segura , C. Torres ,

G. Gemma , M. Tur , A. Fernandez , C. Merino

Psychiatry Unit, Can Misses Hospital, Psychiatry, Ibiza, Spain

Corresponding author.

Introduction

Hyponatraemia occurs in 4% of schizophrenic

patients. Dilutional hyponatraemia, due to inappropriate retention

of water and excretion of sodium, occurs with different psy-

chotropic medications and could lead to hippocampal dysfunction.

This complication is usually asymptomatic but can cause severe

problems, as lethargy and confusion, difficult to diagnose in men-

tally ill patients.

Objectives

To describe a case of a patient with psychotropic

poli-therapy, admitted three times due to hyponatremia and the

pharmacological changes that improved his condition.

Aims

To broadcast the intermittent hyponatraemia and polydip-

sia (PIP), a not rare condition, suffered by treated schizophrenic

patients and discuss its physiopathology and treatment thorough

a case report.

Methods

A 56-year schizophrenic male was admitted for pre-

senting disorganized behavior, agitation, auditory hallucinations,

disorientation, ataxia, vomits and urinary retention. He was on

clomipramine, haloperidol and clotiapine (recently added), que-

tiapine, fluphenazine and clonazepam. After water restriction his

symptoms improved and he was discharged. Twenty-five days

later, he was readmitted for presenting the same symptoms and

after water restriction, he was discharged. Five days later, he was

again admitted and transferred to the psychiatric ward.

Results

Haloperidol, fluphenazine and clomipramine were

replaced by clozapine. These changes lead him to normalize the

hypoosmolality and reduce hiswater-voracity. Endocrinology team

did not label this episode of SIADH due to its borderline blood and

urine parameters.

Conclusions

Hyponatremia is frequent in schizophrenic patients

and may have severe consequences. Therefore, a prompt recogni-

tion and treatment is warranted.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.632

EV0303

Clozapine induced diarrhea

S. Ramos-Perdigues

, M.J. Gordillo , C. Caballero ,

S. Latorre , S.V. Boned , M.T. Sanchez , P. Torres ,

M. Guisado , E. Contreras , M. De Almuedo , E. Esmeralda ,

E. Sanchez , M. Segura , A. Fernandez , C. Torres , G. Herrero ,

M. Tur , C. Merino

Psychiatry Unit, Can Misses Hospital, Psychiatry, Ibiza, Spain

Corresponding author.

Introduction

Clozapine (CZP) is the only antipsychotic approved

for resistant schizophrenia 1. Due to its side effects, CZP is not the

first therapeutic option in a psychotic episode. Its anticholinergic

effects often cause constipation, however, diarrhea have also been

described in literature.

Objectives

We describe a patient with two episodes of severe

diarrhea after clozapine initiation, which lead to CZP discontinu-

ation.

Aims

Discuss about the differential diagnosis of diarrhea in CZP

patients and the needing of a further studies for clarify the more

appropriate management in CZP induced diarrhea.

Methods

We present a case report of a 46 years man diagnosed

with schizoaffective disorderwho presented two episodes of severe

diarrhea with fever, which forced his transfer to internal medicine

and UCI after CZP initiation.

Results

At the first episode analytical, radiological and histo-

logical findings led to Crohn’s disease diagnosis, which required

budesonide and mesalazine treatment. In the second episode, the

digestive team concluded that the episode was due to clozapine

toxicity despite the controversial findings (clostridium toxin and

Crohn’s compatible biopsies)

Conclusions

Diarrhea caused by CZP has been controversial in the

literature. However due to the severity of digestive episodes and

the paucity of alternative treatments further studies for a better

understanding of its physiopathology are warranted.

Disclosure of interest

The authors have not supplied their decla-

ration of competing interest.

http://dx.doi.org/10.1016/j.eurpsy.2017.01.633

EV0304

The unnoticed interictal disphoric

disorder

S. Ramos-Perdigues

1 ,

, E. Bailés

2

, A. Mané

3

, L. Pintor

4

1

Psychiatry Unit, Can Misses Hospital, Psychiatry, Ibiza, Spain

2

Univeristy Pompeu Fabra, Psychology, Barcelona, Spain

3

Institute of Neuropsychiatry and Addictions, Psychiatry, Barcelona,

Spain

4

Epilepsy Unit, Hospital Clinic of Barcelona, Psychiatry, Barcelona,

Spain

Corresponding author.

Introduction

Psychiatric morbidity in refractory epilepsy is

frequent and has a negative influence on quality of life. Treatment-

refractory epileptic patients are at higher risk of developing

psychiatric disturbances. The interictal dysphoric disorder (IDD)

has been described as a pleomorphic pattern of symptoms claimed

to be typical of patients with epilepsy. It is characterized by 3/8

symptoms: depressivemood, anergia, pain, insomnia, fear, anxiety,

irritability, and euphoric mood.

Objectives

To provide evidence that psychiatric morbidity is high

in refractory epilepsy and to describe associations to IDD.

Aims

The present study aims to show that there are typical psy-

chiatric conditions in epilepsy that can be unnoticed.

Methods

We cross-sectional analyzed the psychopathologic out-

comes of patients with refractory epilepsy. The assessments

methods included SCID for DSM-IV and clinical interview for

epileptic specific psychiatric conditions.

Results

The sample consists of 153 patients, with a mean age

of 37. A total of 42.5% were males. One or more Axis I diagnoses